- Associate Professor, Global Health
- Associate Professor, Epidemiology
Ninth and Jefferson Building
325 Ninth Avenue, Box 359927
Seattle, WA 98104
Select from the following:
Dr. Heffron is a member of the faculty of Global Health and jointly appointed in Epidemiology and she has been working within the International Clinical Research Center since 2008. Her research, teaching, and mentoring focuses on advancing the field of HIV prevention, often by leveraging intersections with reproductive health. Currently, she has been particularly focused on oral PrEP and utilizing a variety of methods from the fields of clinical epidemiology and implementation science, including clinical trials and observational studies, causal inference, qualitative research, to study effectiveness and optimizing delivery of oral PrEP among young women and HIV serodiscordant couples in sub-Saharan Africa. For all of this work, she collaborates extensively with colleagues in Kenya, Uganda, South Africa, and Lesotho. She teaches HIV/STI Research Methods in Spring Quarter and mentors PhD and MPH students from her departments.
- PhD (University of Washington)
- MPH (Tulane University)
- BA (Boston University)
- Child and Adolescent Health (incl. Pediatrics)
- Family Planning
- HIV Transmission
- Infectious Diseases
- Male Circumcision
- Maternal Child Health (incl. Reproductive Health)
- Mobile Health (mHealth)
- STDs (other than HIV)
- Effects of Contraceptives on Genital Immunity and HIV Susceptibility
- Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women
- Integrated PrEP and ART Delivered in Ugandan Public Health Clinics to Improve HIV and ART Outcomes for HIV Serodiscordant Couples
- Optimizing PrEP Delivery in Lesotho
- PrEP and safe abortion insights generation
Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, Kidoguchi L, Donnell D, Mugo N, Bukusi E, Katabira E, Asiimwe S, Morton J, Morrison S, Haugen H, Mujugira A, Haberer J, Ware N, Wyatt M, Marzinke MA, Frenkel LM, Celum C, Baeten JM; Partners Demonstration Project Team. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: Uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res. 2017;1:3 [original work]. doi: 10.12688/gatesopenres.12752.1. PMCID: 5757790.
Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten J; Partners in Prevention HSV/HIV Transmission Study Team. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. 2012;12:19-26.
Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, Ngure K, Kiarie J, Mugo N, Heffron R. Increased risk of female HIV-1 acquisition throughout pregnancy and postpartum: A prospective per-coital act analysis among women with HIV-1 infected partners. J Infect Dis. Published online 05 Mar 2018 [original work]. doi: 10.1093/infdis/jiy113.
Heffron R, Mugo N, Hong T, Celum C, Marzinke M, Ngure K, Asiimwe S, Katabira E, Bukusi E, Odoyo J, Tindimwebwa E, Bulya N, Baeten JM; Partners Demonstration Project and the Partners PrEP Study Teams. Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention. AIDS. In press [original work].
Heffron R, McClelland S, Balkus JE, Celum C, Cohen CR, Mugo N, Bukusi E, Donnell D, Lingappa J, Kiarie J, Fiedler T, Munch M, Fredricks D, Baeten JM; Partners PrEP Study Team. Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: A post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. Lancet HIV. 2017;4:e449-56 [original work]. doi: 10.1016/S2352-3018(17)30110-8. PMCID: 5649365.